Ashley Williams
Director - Research & Development SiVEC Biotechnologies
Seminars
Thursday 18th September 2025
Advancing mRNA-Based Therapeutics for Targeting RAS Mutations with Enhanced Specificity & Versatility
12:00 pm
- Addressing RAS mutation subtypes through mRNA technology
- Enhance specificity, tolerability and versatility of RAS-targeted therapies with mRNA
- Altering and adapting mRNA platforms to address challenges of tumor heterogeneity and evolving mutations
